Taiwan

Taiwan has emerged as a premier destination for the global life sciences industry, seamlessly blending its world-class information and communications technology (ICT) with advanced biotechnology.

Best known for its robust CDMO capabilities, Taiwan is a critical link in the global supply chain for biologics, cell and gene therapies and small molecule drugs.

The nation's healthcare innovation is anchored by the Taiwan National Health Insurance (NHI) database, a massive repository of real-world evidence that fuels AI-driven diagnostics and precision medicine research.

In the medical device sector, Taiwan excels in smart medical devices and wearable health technology, leveraging its semiconductor expertise to pioneer Internet of Medical Things (IoMT) solutions.

Academic research in Taiwan is globally recognized, with institutions like Academia Sinica leading the Taiwan Precision Medicine Initiative (TPMI), which hosts the world's largest genomic cohort for Han Chinese populations.

The pharmaceutical landscape is rapidly evolving through the Act for the Development of Biotech and Pharmaceutical Industry, providing tax incentives that attract international clinical trials and foreign direct investment.

Strategically located as a gateway to the Asia-Pacific, Taiwan's biomedical science parks offer a comprehensive innovation ecosystem for startups and multinational corporations alike.

By prioritizing regenerative medicine and digital health, Taiwan is setting new standards for personalized healthcare and global health equity.